Summary
Psychiatric disorders are highly prevalent in Pakistan and burdens the scarce number of psychiatrists present in the country. The establishment of evidence-based clinical practice guidelines (EBCPGs) and primary-care referral pathways within the local context is imperative to make the process efficient. In this Health Policy, we aimed to develop EBCPGs and primary-care referral pathways that are specific to Pakistan's primary-care setting, with the aim of facilitating the management of psychiatric conditions. Ten EBCPGs were created through the GRADE-ADOLOPMENT process; two recommendations were adopted with minor changes, 43 were excluded, and all others were adopted without any changes. Ten primary-care referral pathways for managing ten psychiatric disorders were created and 23 recommendations were added which will help to bridge the gap in care provision. These psychiatric referral pathways and EBCPGs will bring Pakistan's healthcare system a step closer to achieving optimal health outcomes for patients.
Keywords: Psychiatry, Clinical practice guidelines, Pakistan, Referral
Introduction
By 2030, the WHO estimates that mental health issues will become the leading contributor to rising morbidities in the modern world.1 Currently, mental health disorders account for 10–13% of the global disease burden,2 with a worrying proportion of patients not receiving adequate treatment. This unmet need for psychiatric care can be as high as 90% in low-income and middle-income countries (LMICs) like Pakistan. Pakistan's mental health indicators are particularly concerning, as the country has a considerable burden of psychiatric disorders but spends a meagre 0.4% of its budget on mental health.3 While no official numbers exist, Pakistan has approximately 400 psychiatrists across a population of more than 220 million, with most psychiatrists being based in urban areas.4 This leaves many people from rural settings and slum areas around major urban centres without adequate access to psychiatric care. An estimated 50 million or more people in Pakistan may be afflicted with mental disorders.5 The meagre annual household income per capita of around 600 US$ ensures many of these patients either go untreated or are forced to turn to faith healers and homeopathic remedies.6 A dire lack of funding and poor handling of existing funds further exacerbates the situation.5
Evidence-based clinical practice guidelines (EBCPGs) provide a clear and consistent framework for patient care, basing recommendations off a comprehensive synthesis of high-quality evidence. Globally, several EBCPGs exist, mostly from high-income countries in the western part of the globe, which offer detailed management recommendations for most major psychiatric illnesses. Reliance on these guidelines may help to ensure that uniformity may be achieved in the management of certain psychiatric conditions within a country's healthcare system. However, when implementing these guidelines in different regions, it is important to keep in mind that the psychosocial aspects of psychiatric care can be expected to vary across contexts and settings. Cultural influences have a widespread impact on psychiatric care, particularly for non-pharmacological aspects of management. Additionally, socioeconomic status directly affects the quality of psychiatric care that a patient can afford or access.
LMICs struggle to develop local psychiatry EBCPGs, mainly due to limitations in financial resources, high-quality local evidence, resource infrastructure, and available expertise. This is worrisome, as psychiatric healthcare in LMICs differs in several respects, including insufficient budget allocations, stigmatisation of mental health-related issues, shortage of trained professionals, and inadequate mental health policy. The Mental Health Atlas survey conducted by WHO in 2014 demonstrated that only 24% of countries across the world had independent policies pertaining to mental health.7 This figure is particularly concerning for the African continent, where 46% of countries lacked a stand-alone mental health policy. This, combined with the alarming increase in population and treatment gaps for psychiatric conditions in LMICs in Africa, should serve as a persuasive impetus for national policymakers and researchers to implement standardised psychiatric clinical practice guidelines in their health system.8
Pakistan is one such LMIC that lacks local psychiatric EBCPGs, and the unpresented use of non-local EBCPGs (developed for the healthcare contexts of other countries) presents the issue of unaddressed region-specific concerns in clinical practice. The Pakistan Psychiatric Society has previously published informational resources regarding psychiatric conditions in Pakistan. However, these resources lack clarity regarding the methodology underlying their development, which may limit their credibility and applicability. In addition, they only developed guidelines for eight disorders.9 Therefore, the next most suitable approach for resource-constrained LMICs like Pakistan is to apply context-specific modifications to high-quality internationally developed EBCPGs. The optimal modification process should be based on a combination of adoption (assimilating existing recommendations as is), adaptation (modification of selected recommendations following critical evaluation), and exclusion (omitting recommendations deemed irrelevant to the local context) of existing EBCPGs.10 “Adolopment” is a recently introduced word that encompasses three key elements of adoption, adaptation, and development. The GRADE (Grading of Recommendations, Assessment, Development, and Evaluation)-ADOLOPMENT10 framework uses evidence to decision (EtD) tables to guide this process.11 EtD tables provide general and context-specific evidence across standard criteria (Supplementary Table S1), against which experts judge the appropriateness of existing recommendations and proposed modifications. These modifications may be in the form of a change to the specific population, intervention, or control compared to the original recommendation.
As the disease burden in Pakistan increases, the management of mental illnesses has increasingly become a responsibility of general practitioners (GPs), and the evidence suggests that patient outcomes may remain at par with specialist care for mild to moderate severity illnesses.12 Consequently, there is an immense need for local psychiatry EBCPGs to be developed by following a transparent, standardised process that uses existing and available best-evidence EBCPGs with appropriate context-specific modifications for use by GPs. In addition, a primary care management and referral pathway in the form of a quick and easy-to-follow algorithm will assist GPs in making rapid and informed decisions. Such referral pathways and EBCPGs would bring the healthcare system of Pakistan a step closer to achieving optimal health outcomes in psychiatry and would have greater credibility by virtue of their transparent development processes. Thus, we aimed to employ the GRADE-ADOLOPMENT process to develop local evidence-based EBCPGs and primary care algorithms for managing common adult psychiatric conditions by GPs in Pakistan.
Methods
Study setting
This initiative was conducted at the CITRIC (Clinical and Translational Research Incubator) Center for Clinical Best Practices (CCBP) at the Aga Khan University Hospital (AKUH) in Pakistan. AKUH is a private, non-profit institute, and is one of Pakistan's leading medical and biomedical research institutes. AKUH's CITRIC CCBP deals with the adaptation and development of EBCPGs and care channels to standardise and improve healthcare in Pakistan and other LMICs. The GRADE-ADOLOPMENT processes outlined in this study was employed by the CCBP, in collaboration with the Department of Psychiatry at AKUH, and the GRADE-USA networking group, in the development of EBCPGs for the management of common psychiatric disorders at the level of primary care in Pakistan. The team has used a similar process to create local guidelines for the management of chronic respiratory conditions and type-2 diabetes in Pakistan.13,14 The decision to develop these guidelines for GPs rather than psychiatrists is due to the growing global trend in mental health care being offered by GPs, as well as due to a dearth of specialists in Pakistan.15 Given the lack of involvement of patients or other human participants, a waiver of ethics approval and informed consent was obtained from the Ethics Review Committee of the Aga Khan University. All methods were conducted in accordance with the highest ethical standards outlined in the 1964 Declaration of Helsinki and its future amendments.
Study team
The study team was comprised (i) CCBP staff, who have extensive experience in the development of management EBCPGs, and (ii) Department of Psychiatry at AKUH which included four senior attending psychiatrists (more than four years of practice) and the Head, Department of Psychiatry.
Source guideline selection
Supplementary Figure SA depicts the process followed to create the guidelines and referral pathways. The source guideline is the single, original, “parent” EBCPG that underwent the GRADE-ADOLOPMENT process in the development of a local EBCPG. Three local expert psychiatrists evaluated available guidelines by performing an extensive literature review on Google Scholar and PUBMED from January 2000 to December 2021. The local expert psychiatrists considered local familiarity, scope, applicability, thoroughness, and integrity of creating bodies for each EBCPG. After careful consideration, the experts decided to use ten American Psychiatric Association (APA) guidelines as the source guidelines and to standardise the local guidelines because the APA guidelines are the most used and familiar guideline locally and were assessed to have good methodological quality. However, for the delirium guidelines, to incorporate the neurological perspective, the European Federation of the Neurological Societies guideline was also used which fulfilled the same criteria for selection. The following ten openly available EBCPGs developed by APA, and one developed by the European Federation of the Neurological Societies were chosen to undergo the GRADE-ADOLOPMENT process.
-
•
Practice Guideline for the Treatment of Patients with Bipolar Disorder (revision)—200216
-
•
Practice Guideline for the Treatment of Patients with Obsessive-Compulsive Disorder—200717
-
•
Practice Guideline for the Treatment of Patients with Schizophrenia (Third Edition)—202018
-
•
Practice Guideline for the Treatment of Patients with Acute Stress Disorder and Posttraumatic Stress Disorder—200419
-
•
Practice Guideline for the Treatment of Patients with Major Depressive Disorder—201020
-
•
Practice Guideline for the Treatment of Patients with Panic Disorder—200921
-
•
Practice Guideline for the Treatment of Patients with Delirium—201022
-
•
Practice Guideline for the Treatment of Patients with Alzheimer's disease and Other Dementias—200723
-
•
EFNS guidelines for the diagnosis and management of Alzheimer's Disease. European Journal of Neurology 201024
-
•
Practice Guideline for the Treatment of Patients with Eating Disorders—200625
-
•
Practice Guideline for the Treatment of Patients with Substance Use Disorders 200726
These were selected as the source EBCPGs due to their comprehensive set of recommendations, integrated approach to management, and high-quality synthesis of available evidence.
Guideline content review
A Table of Recommendations (ToR) was made by extracting and compiling all recommendations mentioned in the source EBCPGs. Two senior attending psychiatrists reviewed each ToR independently and marked each recommendation as either “Adopt”, “Adapt” or “Exclude.” Discrepancies were settled in consensus with the Head, Department of Psychiatry. Recommendations marked “Adopt” were incorporated into the local EBCPG with no further changes or with minor changes, while those marked “Exclude” were omitted from the local EBCPG. Exclusions were based on recommendations pertaining to pediatric and inpatient, healthcare services or medications unavailable in Pakistan, or if otherwise deemed irrelevant to the local context. Recommendations marked “Adapt” were planned to undergo review and revision via the GRADE-ADOLOPMENT process via GRADEPro (Supplementary Material) before incorporation into local EBCPGs.
Our adolopment process had some differences from the original process. In contrast to the original process10 where every recommendation was subjected to complete adaptation process via EtD tables and expert panel review, we adopted recommendations with minor changes that only required minor and straightforward changes, which did not affect the recommendation's meaning but rather provided supporting information or clarification. Based on the expert review, we concluded that no recommendation needed adaptation.
Following the creation of the guidelines, we sought to ensure the validity and comprehensiveness of the local guideline by engaging an external psychiatry expert. The expert was a Professor and Head of the Department of Psychiatry at one of the major private medical colleges in the country. The expert was invited to review the modifications made to the source guideline and provide their professional assessment. Changes, if any, were discussed in collaboration with the expert Psychiatrists at AKU and subsequently synthesised into the final version of the local guidelines.
Referral care pathway creation
The Head, Department of Psychiatry worked with the CCBP faculty to develop management algorithms for primary care providers. A draft of the clinical referral pathway was made using the recommendations found in the EBCPGs. However, if any gaps were identified during the formation of the clinical management and referral pathways, additional recommendations were sought through a best-evidence systematic review process (Supplementary Material), including pre-existing EBCPGs. If suitable pre-existing EBCPGs were not found, we integrated recommendations using peer-reviewed evidence from reputable information sources. The evidence used to develop each recommendation was reviewed by the local experts and the final version of the primary care referral pathway was made.
Final debriefing to identify challenges and explore solutions
Two focus group discussions (FGDs) were held to highlight problems encountered during the guideline creation process and to propose potential solutions. A CCBP team member served as the FGD leader. The moderator was chosen due to their qualifications and experience, including a medical degree, training in GRADE methodology, and a postgraduate public health degree. The CCBP staff, four senior attending psychiatrists from the Department of Psychiatry, a scribe and the moderator participated in the FGDs. Both FGDs were conducted in English language and were an hour long. The scribe recorded the audio of the session and took notes. Prior to the FGD, participants were given the chance to independently produce problems and potential solutions faced during the process which were then discussed during the meeting. After the session was complete, two researchers went through the scribes’ notes and the audio recording to identify and list the challenges and solutions and each challenge was classified as either a major or minor challenge according to the consensus. The final list of specific difficulties was then categorised by the CCBP team into broad themes, and the related negatory solutions were then provided alongside them.
Results
Ten EBCPGs were created through the GRADE-ADOLOPMENT process; two recommendations were adopted with minor changes, 43 were excluded, and all others were adopted as is into the local EBCPGs (Fig. 1 and Table 1). The complete EBCPG can be found in the Supplementary Material. Ten primary-care referral pathways for managing these psychiatric disorders were also created. The focus was on early detection and diagnosis, primary care management, and prompt referral to specialists. 23 recommendations were added across the 10 referral pathways (Fig. 1, Table 1, and Supplementary Figures S1–S10).
Fig. 1.
Outcomes of Psychiatry evidence-based clinical practice guideline (EBCPG) and referral pathways.
Table 1.
Recommendations adopted with minor changes or excluded in the evidence-based clinical practice guideline (EBCPG) and recommendations added to the referral pathways for management of psychiatric conditions in Pakistan (text in bold indicates it has been added or modified).
| Action | Recommendation | Source or reason for exclusion |
|---|---|---|
| General recommendations for the management of psychiatric conditions | ||
| Added | Combination of 2 SSRIs or SSRI with SNRI does not augment treatment | Insufficient evidence exists to support augmentation APA20 |
| Added | Before starting, ensure patients are aware that SSRIs take 2–4 weeks before the effects start to appear | National Institute for Health Care and Excellence,27 National Health Service28 |
| Added | To evaluate the risk of suicide or self-harm, use Triage Tool. Patients can also be evaluated using ASQ tool and the Beck Scale for Suicide Ideation (BSI) to determine risk of suicidality. BSI may be used in Urdu when required29 | National Institute for Occupational Safety and Health,30 National Institute of Mental Health31 |
| Added | To assess patient's tendency to cause harm to others, use assault and homicidal danger assessment tool or indicator, such as Triage Tool. The Danger Assessment Tool can also be used to assess risk to healthcare personnel | National Institute for Occupational Safety and Health30 |
| Bipolar Disorder | ||
| Added | Counsel regarding medication use, side effects, and disease or treatment related misconceptions (if any) | National Institute for Health Care and Excellence32 |
| Obsessive Compulsive Disorder | ||
| Added | Counsel regarding medication use, side effects, and disease or treatment related misconceptions (if any) | National Institute for Health Care and Excellence,33 American Family Physician,34 National Institute of Mental Health35 |
| Excluded | “When OCD is of disabling severity, the psychiatrist may need to write on the patient's behalf to government agencies that control access to disability income, publicly financed health care, or government-supported housing; or to tax authorities, courts, schools, or employers [I]” | Reason for exclusion: Unavailable in Pakistan |
| Excluded | “There are no controlled studies that demonstrate effectiveness of dynamic psychotherapy or psychoanalysis in dealing with the core symptoms of OCD. Psychodynamic psychotherapy may still be useful in helping patients overcome their resistance to accepting a recommended treatment by illuminating their reasons for wanting to stay as they are (e.g., best adaptation, secondary gains) [III]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “It may also be useful in addressing the interpersonal consequences of the OCD symptoms [II]. Motivational interviewing may also help overcome resistance to treatment [III]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “Useful strategies to manage medication side effects include small doses of modafinil to minimize fatigue or sleepiness” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “Clinicians should consider booster sessions for more severely ill patients, for patients who have relapsed in the past, and for patients who show signs of early relapse [II]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “Combined SRI and CBT treatment may be provided when the patient has a co-occurring disorder that is SRI-responsive [I]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “Another option in the case of partial response to ERP therapy is to increase the intensity of treatment (e.g., from weekly to daily sessions) [III]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “Some evidence suggests that adding cognitive therapy to ERP may enhance the results, but this remains to be established [III]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “After first- and second-line treatments and well-supported augmentation strategies exhausted, can consider augmenting SSRIs with clomipramine, buspirone, pindolol, riluzole, or once-weekly oral morphine sulfate” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “However, morphine sulfate should be avoided in patients with contraindications to opiate administration, and appropriate precautions and documentation should occur. If clomipramine is added, appropriate precautions should be utilized with regard to preventing potential cardiac and central nervous system side effects [I]” |
Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “Less well-supported monotherapies to consider include d-amphetamine, Tramadol, Monoamine oxidase inhibitors, Ondansetron, Transcranial magnetic stimulation, and deep brain stimulation [III]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “Intensive residential treatment or partial hospitalization may be helpful for patients with severe treatment-resistant OCD [II]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “Ablative neurosurgery for severe and very treatment-refractory OCD is rarely indicated and, along with deep brain stimulation, should be performed only at sites with expertise in both OCD and these treatment approaches [III]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Schizophrenia | ||
| Added | Counsel regarding medication use, side effects, and disease or treatment related misconceptions (if any) | National Institute for Health Care and Excellence,36 National Health Service,37 American Journal of Psychiatry38 |
| Added | Monitor neutrophil count weekly during the first six months of clozapine administration, every other week for the second six months and every four weeks after one year for the duration of treatment. Also monitor closely for symptoms of myocarditis during initial four weeks of treatment | National Health Service,39 National Institute for Health Care and Excellence40 |
| Excluded | “Patients who have moderate to severe or disabling tardive dyskinesia associated with antipsychotic therapy be treated with a reversible inhibitor of the vesicular monoamine transporter 2 (1B)” | Reason for exclusion: Unavailable in Pakistan |
| Excluded | “Patients with schizophrenia be treated with cognitive behavioral therapy for psychosis (1B)” | Reason for exclusion: Beyond the scope of a General Practitioner |
| Excluded | “Patients with schizophrenia receive supported employment services (1B)” | Reason for exclusion: Unavailable in Pakistan |
| Post-Traumatic Stress Disorder and Acute Stress Disorder | ||
| Added | Counsel regarding medication use, side effects, and disease or treatment related misconceptions (if any) | National Institute for Health Care and Excellence,41 American Psychological Association,42 National Institute of Mental Health43 |
| Added | Counsel regarding the importance of family in supporting patient, and encourage the practice of religion and spirituality | National Institute of Mental Health,43 US Department of Veterans Affairs44 |
| Major Depressive Disorder | ||
| Added | Continue medications for nine months, or six months after stability achieved | National Institute for Health Care and Excellence27 American Psychiatry Association,45 National Institute of Mental Health46 |
| Adopt with Minor Changes | “Treatment in the acute phase may include pharmacotherapy, depression-focused psychotherapy, and combination of pharmacological and psychotherapy or provide adequate referral for other somatic therapies such as electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), or light therapy. Selection of an initial treatment modality should be influenced by clinical features (e.g., severity of symptoms, presence of co-occurring disorders or psychosocial stressors) as well as other factors (e.g., patient preference, prior treatment experiences)” | Changes made: Refer for ECT, TMS, and Light Therapy as they are beyond the scope of a general physician. Source: American Psychiatry Association,45 National Institute of Mental Health47 UpToDate48 |
| Excluded | “Patients who refuse inpatient treatment can be hospitalized involuntarily if their family is on board. Condition meets the criteria of the local jurisdiction for involuntary admission [I]” | Reason for exclusion: no laws for involuntary admission |
| Excluded | “Admission to a hospital or, if available, an intensive day program, may also be indicated for severely ill patients who lack adequate social support outside of a hospital setting, who have complicating psychiatric or general medical conditions, or who have not responded adequately to outpatient treatment [I]” | Reason for exclusion: no day programs available in Pakistan |
| Excluded | “In general, the use of nonselective monoamine oxidase inhibitors (MAOIs) (e.g., phenelzine, tranylcypromine, isocarboxazid) should be restricted to patients who do not respond to other treatments [I], given the necessity for dietary restrictions with these medications and the potential for deleterious drug–drug interactions” | Reason for exclusion: nonselective MAOIs are unavailable |
| Excluded | “Use of a depression-focused psychotherapy alone is recommended as an initial treatment choice for patients with mild to moderate major depressive disorder [I]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “Clinical evidence supporting the use of cognitive behavioral therapy (CBT) [I] Interpersonal psychotherapy [I] Psychodynamic therapy [II] Problem-solving therapy [III] In individual [I] and in group [III] formats” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “Considerations in the choice of a specific type of psychotherapy include the goals of treatment (in addition to resolving major depressive symptoms), prior positive response to a specific type of psychotherapy, patient preference, and the availability of clinicians skilled in the specific psychotherapeutic approach [II]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “When determining the frequency of psychotherapy sessions for an individual patient, the psychiatrist should consider multiple factors, including the specific type and goals of psychotherapy, symptom severity (including suicidal ideas), co-occurring disorders, cooperation with treatment, availability of social supports, and the frequency of visits necessary to create and maintain a therapeutic relationship, ensure treatment adherence, and monitor and address depressive symptoms and suicide risk [II]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “For patients in psychotherapy, additional factors to be assessed include the frequency of sessions and whether the specific approach to psychotherapy is adequately addressing the patient's needs [I]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “With some TCAs, a drug blood level can help determine if additional dose adjustments are required [I]” | Reason for exclusion: Unavailable in Pakistan |
| Excluded | “Particularly for those who have shown minimal improvement or experienced significant medication side effects, other options include augmenting the antidepressant with a depression-focused psychotherapy [I] or with other agents [II]” | Reason for exclusion: Redundant |
| Excluded | “Medication can be changed to non-MAOI antidepressant in patients with minimal improvement or those with significant medication side effects” | Reason for exclusion: Unavailable in Pakistan |
| Excluded | “In patients capable of adhering to dietary and medication restrictions, an additional option is changing to a nonselective MAOI [II]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “Enough time should be provided between medication to avoid deleterious interactions” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “Transdermal selegiline, a relatively selective MAO B inhibitor with fewer dietary and medication restrictions, or transcranial magnetic stimulation could also be considered [II]” | Reason for exclusion: Unavailable in Pakistan |
| Excluded | “Vagus nerve stimulation (VNS) may be an additional option for individuals who have not responded to at least four adequate trials of antidepressant treatment, including ECT [III]” | Reason for exclusion: Unavailable in Pakistan |
| Excluded | “For patients treated with psychotherapy, consideration should be given to increasing the intensity of treatment or changing the type of therapy [II]” | Reason for exclusion: Redundant |
| Excluded | “If psychotherapy is used alone, the possible need for medications in addition to or in lieu of psychotherapy should be assessed [I]” | Reason for exclusion: Redundant |
| Excluded | “Patients who have a history of poor treatment adherence or incomplete response to adequate trials of single treatment modalities may benefit from combined treatment with medication and a depression-focused psychotherapy [II]” | Reason for exclusion: Redundant |
| Excluded | “Maintenance treatment with VNS is also appropriate for individuals whose symptoms have responded to this treatment modality [III]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “Catatonic features that occur as part of a major depressive episode should be treated with a barbiturate” | Reason for exclusion: Beyond the scope of General Practitioner, to be referred to a tertiary care setting for further management |
| Excluded | “When possible, a period of substance abstinence can help determine whether the depressive episode is related to substance intoxication or withdrawal [II]” | Reason for exclusion: Beyond the scope of General Practitioner |
| Excluded | “Selegiline has antiparkinsonian and antidepressant effects but may interact with l-dopa and with other antidepressant agents [I]” | Reason for exclusion: Unavailable in Pakistan |
| Panic Disorder | ||
| Added | Counsel regarding medication use, side effects, and disease or treatment related misconceptions (if any) | National Institute for Health Care and Excellence,49 American Family Physician,50 National Institute of Mental Health,51 National Health Service52 |
| Added | Continue medications for nine months, or six months after stability achieved | National Institute for Health Care and Excellence,49 American Family Physician50 |
| Dementia | ||
| Added | Counsel regarding medication use, side effects, and disease or treatment related misconceptions (if any) | National Institute for Health Care and Excellence,53 National Health Service,54 National Institute of Neurological Disorders and Stroke28,55 |
| Added | Careful monitoring and prescription are recommended for benzodiazepines as cognition can worsen with its use | American Geriatric Society,56 |
| Added | Cognitive Exercises can improve memory and problem solving and slow down cognitive decline (72). They are most effective when paired with physical exercise and healthy diet (73) | American Psychiatry Association,57 World Health Organization58 National Institute of Neurological Disorders and Stroke55 |
| Delirium | ||
| Added | Aim to rule out dementia on subsequent follow up | National Institute for Health Care and Excellence59 |
| Added | Close monitoring is required as delirium can continue for weeks after medical issue is resolved | National Institute for Health Care and Excellence59 |
| Added | Counsel regarding medication use, side effects, and disease or treatment related misconceptions (if any) | National Institute for Health Care and Excellence59 |
| Adopt with Minor Changes | “Haloperidol is most frequently used because it has few anticholinergic side effects, few active metabolites, and a relatively small likelihood of causing sedation and hypotension. Haloperidol may be administered orally, intramuscularly, or intravenously and may cause fewer extrapyramidal symptoms when administered intravenously. Haloperidol can be initiated in the range of 1–2 mg every 2–4 h as needed (0.25–0.50 mg every 4 h as needed for elderly patients), with titration to higher doses for patients who continue to be agitated. For patients who require multiple bolus doses of antipsychotic medications, continuous intravenous infusions of antipsychotic medication may be useful (e.g., haloperidol bolus, 10 mg i.v., followed by continuous intravenous infusion of 5–10 mg/h; lower doses may be required for elderly patients). For patients who require a more rapid onset of action, haloperidol can be considered followed by the newer antipsychotic medications (risperidone, olanzapine, and quetiapine) in the treatment of patients with delirium. Patients receiving antipsychotic medications for delirium should have their ECGs monitored. A QTc interval greater than 450 msec or more than 25% over baseline may warrant a cardiology consultation and reduction or discontinuation of the antipsychotic medication. [I]” |
Reason for change: Unavailability of droperidol in Pakistan |
| Eating disorders | ||
| Added | Urgent referral is required for hypotension, bradycardia, arrythmias, hypoglycaemia, syncope, dehydration, refeeding syndrome, BMI<15 kg/m2 | National Institute for Health Care and Excellence,60 American Family Physician61 |
| Added | Counsel regarding medication use, side effects, and disease or treatment related misconceptions (if any) | National Institute for Health Care and Excellence,60 American Family Physician61 |
| Added | Start fluoxetine when weight is stabilized to prevent relapse. | UpToDate62 |
| Substance abuse | ||
| Added | Counsel regarding medication use, side effects, and disease or treatment related misconceptions (if any) | World Health Organization,63 American Psychiatry Association,64 National Institute on Drug Abuse65 |
ASQ: Ask Suicide-Screening Questions, BSI: Beck Scale for Suicide Ideation, CBT: Cognitive behavioral therapy, ECT: Electroconvulsive therapy, ERP: Exposure and Response Prevention, MAOI: Monoamine oxidase inhibitor, OCD: Obsessive compulsive disorder, SNRI: Serotonin and norepinephrine reuptake inhibitors, SSRI: Selective serotonin reuptake inhibitor, TCA: Tricyclic antidepressant, TMS: Transcranial magnetic stimulation, VNS: Vagus nerve stimulation.
The challenges faced were broadly categorised into four main themes: resources, stakeholder support and involvement, resistance to change, and methodological limitations (Table 2).
Table 2.
Challenges faced and proposed solutions.
| Category of challenge | Specific challenge | Proposed solution |
|---|---|---|
| Resources |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stakeholder support and involvement |
|
|
|
|
|
| ||
| ||
| ||
| ||
| Resistance to change |
|
|
| ||
|
|
|
| Methodological limitations |
|
|
| ||
| ||
|
|
Minor challenge.
Major challenge; EBCPG–evidence-based clinical practice guidelines.
Discussion
We described our use of the GRADE-ADOLOPMENT process for creating local EBCPGs for the practice of psychiatry at the level of the GP in Pakistan. These EBCPGs were then framed into ten thorough, easy-to-follow primary care referral pathways for GPs. These referral pathways were designed to help GPs to easily understand and implement the EBCPGs and provide appropriate referrals to specialist mental health services when indicated.
Referral pathways bridge primary healthcare with secondary healthcare provided by specialists. These pathways serve as a vital means of communication and collaboration, ensuring that patients receive the most effective care possible. In particular, clinical referral pathways play a pivotal role in supporting GPs in fulfilling their critical role throughout the entire continuum of care. By starting with the screening and identification of potential psychiatric illnesses, these pathways enable GPs to refer patients to the appropriate specialists for further diagnosis, treatment, and management. A practical healthcare referral pathway for psychiatric conditions has several benefits: it can relieve the burden on scarce specialists, accelerate the provision of healthcare, improve the quality of clinical information in referrals, and reduce the number of unnecessary referrals.66 A study in New Zealand suggested that better integrated primary-to-secondary care pathways were needed to improve the quality of referrals and care provision.67 Another study by Wadoo and colleagues found that improvements in primary health care referrals at a mental health clinic in Qatar resulted in a 93% reduction in referrals with incomplete information, an 80% decrease in referrals that should have been directed elsewhere, and received positive feedback from the primary care physicians.68 Thus, the referral pathways we have created have the potential to bring about similarly positive changes.
In the context of LMICs, implementation of primary care management and referral pathways and EBCPGs could prove immensely beneficial. Greater than 85% of the world's population resides in LMICs, and greater than 80% of people suffering from mental disorders live in LMICs.69 In many LMICs, particularly in Africa and southeast Asia, there is a worrisome absence of mental health policies and laws to provide direction for their mental health programs and services.70 Additionally, a significant number of LMICs, including those in Africa, allocate less than 1% of their healthcare budget towards addressing mental health concerns.71 Hence, there is an urgent need to revisit existing mental health care systems to counter these alarming numbers. The implementation of EBCPGs is becoming increasingly recognised to improve the quality of healthcare.72 The integration of standardised EBCPGs has resulted in fewer discrepancies in the quality of patient care and better patient outcomes.66 Therefore, using standardised EBCPGs presents a promising tool to bring about a much-needed improvement in mental health care provision quality within LMICs such as Pakistan. Several countries have reported shorter treatment delays when patients first seek help from primary health care services instead of eliciting the help of traditional health practitioners.73 A study in Iran concluded that using GPs as the first contact resulted in a lower duration of untreated psychosis for patients with schizophrenia.74 Therefore, well-developed, and accessible primary care pathways can significantly improve measurable health parameters. The success of Colombia lends further support to incorporating standardised EBCPGs into LMICs. The EBCPGs proposed by Colombia in 1998 have now matured into reliable and high-quality (AGREE II) clinical standards implemented routinely nationwide.75 A standardised guideline model has been shown to provide a consistent framework for patient care, provide evidence-based recommendations, remove ambiguity, and offer clarity and uniformity in managing various mental health problems.76,77
To maximise the advantages of adopting the primary care referral pathways presented in this study, it is important to consider the types of mental health care provided at the primary care level. Because improvements in the quality of psychiatric referrals rely on the range of mental health care coverage found at the primary care level, increasing the range of mental health care at the base can directly improve access to care, the quantity and quality of referrals, the number of timely diagnoses made and the early initiation of treatments or therapies. Several high-income countries have begun incorporating cognitive behavioral therapy (CBT) and other forms of therapy in primary care.78 Therefore, to maximise benefit, the implementation of revised primary care pathways must be complemented by an expansion in the types of mental health care available at the primary care level. To aid this process, physicians should familiarise themselves with various manuals available.79 Provision of CBT at the primary care level will decrease treatment delay and prevent unnecessary referrals for conditions manageable by a GP.
Our study involved a thorough application of the GRADE-ADOLOPMENT process to introduce psychiatric EBCPGs in Pakistan. Table 1 summarises the recommendations which were either excluded or adopted with minor changes from the source guidelines and those that were added to the referral pathways. Several recommendations were excluded because of concerns pertaining to local availability and feasibility at the primary care level. General recommendations which were added for the management of psychiatric conditions in Pakistan included the discouragement of combining two selective serotonin reuptake inhibitors (SSRIs) or an SSRI with a serotonin and norepinephrine reuptake inhibitor (SNRI) because of a lack of evidence to support this augmentation.20 The recommendation to counsel patients on the delay in effects seen with SSRI drug therapy was also incorporated. This is important as many anti-depressants are slow to take effect, and the resulting window of therapeutic latency can be a cause for considerable frustration for patients and can also lead to issues of non-adherence to therapy.80
Furthermore, the use of the Triage Tool to assess a patient's potential to harm others or themselves and the Danger Assessment Tool to evaluate the patient's violent risk to healthcare personnel were added. The Ask Suicide-Screening Questions (ASQ) tools for assessment of suicide risk were also included from the National Institute for Occupational Safety and Health and the National Institute of Mental Health guidelines.30,31 In the primary care setting, the ASQ tool has been tested to have a sensitivity of 100% and a specificity of 87.9%. It was also found to be an effective tool in screening youth for risk of suicide.81 The Beck Scale for Suicide Ideation (BSI) is another Mental Health Triage (MHT) tool that may be used to assess the risk of suicide in psychiatric patients. BSI has a translated version in Urdu (national language of Pakistan) which may benefit in settings where questionnaires in English cannot be utilised.29 Overall, MHT tools in the primary care setting have been shown to cause an increase in patient satisfaction and accessibility to care and led to a rise in adequate and timely care responses for psychiatric patients.82
Going forward, we have several plans to ensure that the guidelines are effectively implemented and disseminated. We plan to incorporate the guidelines into the electronic health record system used in AKUH, which will ensure that the guidelines are easily accessible to healthcare professionals. Additionally, we plan to create and disseminate a “Manual of Therapeutics” that will contain all guidelines being created by the CCBP, which will serve as a comprehensive resource for healthcare professionals in our local setting. We also plan to develop a mobile application that will allow easy access to the guidelines and support remote usage and create a video lecture series delivered by local experts based on the guidelines. We aim to pilot these guidelines in our local setting and other hospitals and clinics. Furthermore, we plan to collaborate with external non-governmental organisations as well as government stakeholders to ensure that the guidelines are disseminated widely and that healthcare professionals are trained in their use. Additionally, to maximise the utility of EBCPGs it is necessary to also prepare GPs adequately for the proper implementation of these EBCPGs. Incentivised and institution-sanctioned training courses and workshops may help accustom GPs to the effective use of these guidelines within the Pakistani healthcare setting. This is important because GPs are able to screen patients en masse, and serve as first responders to psychiatric ailments, and operate as gatekeepers to appropriate specialist care. We believe that these efforts will ensure that the guidelines are effectively implemented and that patients receive the best possible care for their mental health conditions.
The transparency of the GRADE-ADOLOPMENT process will aid GPs in making a more informed decision, while the thorough step-by-step referral pathways will help streamline the referral process. The clear methodology will also aid researchers from other LMICs in developing a similar EBCPG and referral pathway. A limitation of the study is that our panel of experts comprised of four attending psychiatrists and the Head, Department of Psychiatry from the same hospital. A more diversified panel could have minimised individual or institutional biases that may have been involved in the findings.
Conclusion
This study used the GRADE-ADOLPOMENT process to create ten EBCPGs for the management of psychiatric disorders in Pakistan. The recommendations added will help to bridge the gap in care provision and will help the physicians to treat patients holistically. Ten primary care management and referral pathways were also created for use by physicians for a smooth referral process. These psychiatric management and referral pathways, and EBCPGs will bring the healthcare system a step closer to achieving optimal health outcomes for patients.
Contributors
The authors’ contributions were assessed using an objectively ranked score based on their involvement in guideline conceptualisation, guideline creation, manuscript conceptualisation, abstract, introduction, method, results write-up, data visualization (figures and tables), discussion, manuscript critical review, supervision, coordination, and management. TN, NA, RC, NAR, SN, MAM, and AHH were all involved in the conceptualisation process for the guideline. The creation of the guideline, which involved developing a methodology for the study and forming a panel of experts, was done by BA, TN, SSA, RC, NA, AAR, and NAR. AP contributed towards all aspects of the manuscript writing process and was involved in the supervision, coordination, and management of the manuscript development process. RSM, SP, MMB, MIB assisted in the write-up for various sections of the manuscript. All authors critically reviewed the article.
Data sharing statement
All data generated or analysed during this study are included in this published article and its supplementary information files.
Declaration of interests
The authors have no financial or personal conflict of interests to declare. We received no external funding for this research.
Acknowledgements
The authors would like to acknowledge Aisha Noorullah, Shireen Najam, Marium Mansoor, and Abdul Wahab Yousafzai for their contribution towards the guideline creation.
Footnotes
Supplementary data related to this article can be found at https://doi.org/10.1016/j.lansea.2024.100387.
Appendix A. Supplementary data
References
- 1.Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi: 10.1371/journal.pmed.0030442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Khan T.A., Hussain S., Ikram A., et al. Prevalence and treatment of neurological and psychiatric disorders among tertiary hospitals in Pakistan; findings and implications. Hosp Pract. 2020;48(3):145–160. doi: 10.1080/21548331.2020.1762366. [DOI] [PubMed] [Google Scholar]
- 3.Mubbashar M.H. Development of mental health services in Pakistan. Int Psychiatry. 2003;1(1):11–13. [PMC free article] [PubMed] [Google Scholar]
- 4.World Health Organization . 2009. WHO-AIMS country profile: Pakistan.https://www.who.int/publications/m/item/who-aims-country-profile-pakistan [Google Scholar]
- 5.Bashir A. The state of mental health care in Pakistan. Lancet Psychiatr. 2018;5(6):471. doi: 10.1016/S2215-0366(18)30191-3. [DOI] [PubMed] [Google Scholar]
- 6.CEIC Pakistan household income per capita 2019. https://www.ceicdata.com/en/indicator/pakistan/annual-household-income-per-capita#:∼:text=Pakistan%20Annual%20Household%20Income%20per,averaged%20value%20of%20508.977%20USD Available from:
- 7.World Health Organization . World Health Organization; 2015. Mental health atlas 2014.https://apps.who.int/iris/handle/10665/178879 [Google Scholar]
- 8.Sankoh O., Sevalie S., Weston M. Mental health in Africa. Lancet Glob Health. 2018;6(9):e954–e955. doi: 10.1016/S2214-109X(18)30303-6. [DOI] [PubMed] [Google Scholar]
- 9.Pakistan Psychiatric Society First Pakistan psychiatric society national guideline meeting Bhurbhan report 2021. https://ppspk.com/first-pakistan-psychiatric-society-national-guideline-meeting-bhurbhan-report/ Available from:
- 10.Schünemann H.J., Wiercioch W., Brozek J., et al. GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: grade-adolopment. J Clin Epidemiol. 2017;81:101–110. doi: 10.1016/j.jclinepi.2016.09.009. [DOI] [PubMed] [Google Scholar]
- 11.Andrews J.C., Schünemann H.J., Oxman A.D., et al. GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength. J Clin Epidemiol. 2013;66(7):726–735. doi: 10.1016/j.jclinepi.2013.02.003. [DOI] [PubMed] [Google Scholar]
- 12.Renders C.M., Valk G.D., Griffin S.J., Wagner E.H., Eijk van J.T., Assendelft W.J.J. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001;24(10):1821–1833. doi: 10.2337/diacare.24.10.1821. [DOI] [PubMed] [Google Scholar]
- 13.Martins R.S., Hussain H., Chaudry M., et al. GRADE-ADOLOPMENT of clinical practice guidelines and creation of clinical pathways for the primary care management of chronic respiratory conditions in Pakistan. BMC Pulm Med. 2023;23(1):123. doi: 10.1186/s12890-023-02409-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Martins R.S., Masood M.Q., Mahmud O., et al. Adolopment of adult diabetes mellitus management guidelines for a Pakistani context: methodology and challenges. Front Endocrinol. 2022;13 doi: 10.3389/fendo.2022.1081361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Ahmad K. Shortage of psychiatrists a problem in Pakistan. Lancet. 2007;370:817–818. doi: 10.1016/S0140-6736(07)61397-X. [DOI] [PubMed] [Google Scholar]
- 16.Practice guideline for the treatment of patients with bipolar disorder (revision) Am J Psychiatry. 2002;159(4 Suppl):1–50. [PubMed] [Google Scholar]
- 17.Koran L.M., Hanna G.L., Hollander E., Nestadt G., Simpson H.B. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007;164(7 Suppl):5–53. [PubMed] [Google Scholar]
- 18.Keepers G.A., Fochtmann L.J., Anzia J.M., et al. The American psychiatric association practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry. 2020;177(9):868–872. doi: 10.1176/appi.ajp.2020.177901. [DOI] [PubMed] [Google Scholar]
- 19.Ursano R.J., Bell C., Eth S., et al. Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Am J Psychiatry. 2004;161(11 Suppl):3–31. [PubMed] [Google Scholar]
- 20.Gelenberg A.J. The American psychiatric association treatment guideline for major depressive disorder: process and content. Ann Gen Psychiatry. 2010;9(Suppl 1):S46. doi: 10.1186/1744-859X-9-S1-S46. [DOI] [Google Scholar]
- 21.Stein M.B., McIntyre J.S. Retrieved; 2010. Treatment of patients with panic disorder. [Google Scholar]
- 22.Trzepacz P., Breitbart W., Franklin J., Levenson J., Martini D.R., Wang P. Practice guideline for the treatment of patients with delirium Trzepacz PT, cheir American psychiatric association. APA Press; 2010. Treatment of patients with delirium. [Google Scholar]
- 23.Rabins P.V., Blacker D., Rovner B.W., et al. American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Am J Psychiatr. 2007;164(12 Suppl):5–56. [PubMed] [Google Scholar]
- 24.Hort J., O'Brien J.T., Gainotti G., et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol. 2010;17(10):1236–1248. doi: 10.1111/j.1468-1331.2010.03040.x. [DOI] [PubMed] [Google Scholar]
- 25.Treatment of patients with eating disorders, third edition. American Psychiatric Association. Am J Psychiatry. 2006;163(7 Suppl):4–54. [PubMed] [Google Scholar]
- 26.Kleber H.D., Weiss R.D., Anton R.F., Jr., et al. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry. 2007;164(4 Suppl):5–123. [PubMed] [Google Scholar]
- 27.National institute for Health and Care Excellence Depression in adults: treatment and managment 2022. https://www.nice.org.uk/guidance/ng222/resources/depression-in-adults-treatment-and-management-pdf-66143832307909 updated June 29 2022. Available from: [PubMed]
- 28.National Health Service Overview–selective serotonin reuptake inhibitors (SSRIs) national health services Website 2021. https://www.nhs.uk/mental-health/talking-therapies-medicine-treatments/medicines-and-psychiatry/ssri-antidepressants/overview/#:∼:text=When%20they're%20prescribed%2C%20you,t%20stop%20taking%20the%20medicine updated 8 December 2021. Available from:
- 29.Ayub N. Validation of the Urdu translation of the Beck Scale for suicide ideation. Assessment. 2008;15:287–293. doi: 10.1177/1073191107312240. [DOI] [PubMed] [Google Scholar]
- 30.National Institute for Occupational Safety and Health Violence risk assessment tools 2020. https://wwwn.cdc.gov/WPVHC/Nurses/Course/Slide/Unit6_8 updated Febuary 20, 2020. Available from:
- 31.National Institute of Mental Health Ask suicide-screening questions (ASQ) toolkit. https://www.nimh.nih.gov/research/research-conducted-at-nimh/asq-toolkit-materials Available from:
- 32.National Institute for Health and Care Excellence Bipolar disorder: assessment and management 2020. https://www.nice.org.uk/guidance/cg185/resources/bipolar-disorder-assessment-and-management-pdf-35109814379461 updated February 11 2020. Available from: [PubMed]
- 33.National Institute for Health and Care Excellence Obsessive-compulsive disorder and body dysmorphic disorder: treatment 2005. nice.org.uk/guidance/cg31/resources/obsessivecompulsive-disorder-and-body-dysmorphic-disorder-treatment-pdf-975381519301 updated November 29 2005. Available from: [PubMed]
- 34.American Family Physician APA releases guidelines on treating obsessive-compulsive disorder 2008. https://www.aafp.org/pubs/afp/issues/2008/0701/p131.html#:∼:text=The%20U.S.%20Food%20and%20Drug,(Zoloft%3B%20Table%201) updated July 1 2008. Available from:
- 35.National Institute of Mental Health Obsessive-compulsive disorder 2019. nimh.nih.gov/health/topics/obsessive-compulsive-disorder-ocd#part_2230 updated October 2019. Available from:
- 36.National institute for Health and Care Excellence Psychosis and schizophrenia in adults: prevention and management 2014. https://www.nice.org.uk/guidance/cg178/resources/psychosis-and-schizophrenia-in-adults-prevention-and-management-pdf-35109758952133 updated February 12 2014. Available from: [PubMed]
- 37.National Health Service Treatment–schizophrenia 2019. https://www.nhs.uk/mental-health/conditions/schizophrenia/treatment/#:∼:text=Schizophrenia%20is%20usually%20treated%20with,as%20much%20independence%20as%20possible updated November 11 2019. Available from:
- 38.George A., Keepers M.D. The American psychiatric association practice guideline for the treatment of patients with schizophrenia. Am J Psychiatr. 2020;2022(September 11) doi: 10.1176/appi.focus.18402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.National Health Service Clozapine treatment guidelines August 2021. 2021. https://www.candi.nhs.uk/sites/default/files/Clozapine%20Treatment%20guidelines%20_PHA06_August%202021.pdf updated August 2021. Available from:
- 40.National Institute for Health and Care Excellence Clozapine. https://bnf.nice.org.uk/drugs/clozapine/ Available from:
- 41.National Institute for Health and Care Excellence Post-traumatic stress disorder 2018. https://www.nice.org.uk/guidance/ng116/resources/posttraumatic-stress-disorder-pdf-66141601777861 updated December 5 2018. Available from: [PubMed]
- 42.American Psychological Association Clinical practice guidline for the treatment of posttraumatic stress disorder (PTSD) 2017. https://www.apa.org/ptsd-guideline/ptsd.pdf updated Febuary 24 2011. Available from:
- 43.National Institute of Mental Health Post-Traumatic stress disorder 2019. https://www.nimh.nih.gov/health/topics/post-traumatic-stress-disorder-ptsd#part_2241 updated May 2019. Available from:
- 44.US Department of Veterans Affairs Spirituality and trauma: professionals working together 2021. https://www.ptsd.va.gov/professional/treat/care/spirituality_trauma.asp#:∼:text=Aspects%20of%20spirituality%20are%20associated,problems%20in%20some%20trauma%20populations updated November 30, 2021. Available from:
- 45.American Psychiatry Association . 2020. What is depression?https://psychiatry.org/patients-families/depression/what-is-depression updated October 2020. Available from: [Google Scholar]
- 46.National Institute of Mental Health Depression 2022. https://www.nimh.nih.gov/health/topics/depression#part_2257 updated July 2022. Available from:
- 47.National Institute of Mental Health Brain stimulation therapies 2016. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies#part_152879 updated June 2016. Available from:
- 48.UpToDate Unipolar major depression in adults: choosing initial treatment 2021. https://www.uptodate.com/contents/unipolar-major-depression-in-adults-choosing-initial-treatment?search=Depression&source=search_result&selectedTitle=1∼150&usage_type=default&display_rank=1 updated October 7 2021. Available from:
- 49.National Institute for Health and Care Excellence Generalised anxiety disorder and panic disorder in adults: management 2020. https://www.nice.org.uk/guidance/cg113/resources/generalised-anxiety-disorder-and-panic-disorder-in-adults-management-pdf-35109387756997 updated 15 June 2020. Available from: [PubMed]
- 50.American Family Physician 2005. https://www.aafp.org/pubs/afp/issues/2005/0215/p733.html#:∼:text=Antidepressant%20therapy%20should%20continue%20for,symptoms%20before%20they%20become%20debilitating updated Febuary 15, 2005. Available from:
- 51.National Institute of Mental Health Panic disorder: when fear overwhelms 2022. https://www.nimh.nih.gov/health/publications/panic-disorder-when-fear-overwhelms#part_6107 updated 2022. Available from:
- 52.National Health Service Panic disorder 2022. https://www.nhs.uk/mental-health/conditions/panic-disorder/ updated 2020 July 28 Available from:
- 53.National Institute for Health and Care Excellence Dementia: assessment, management and support for people living with dementia and their carers 2018. https://www.nice.org.uk/guidance/ng97/resources/dementia-assessment-management-and-support-for-people-living-with-dementia-and-their-carers-pdf-1837760199109 updated 20 June 2018. Available from: [PubMed]
- 54.National Health Service What are the treatments for dementia? 2020. https://www.nhs.uk/conditions/dementia/treatment/ Available from:
- 55.National Institute of Neurological Disorders and Stroke . 2022. The Dementias: hope through research.https://www.ninds.nih.gov/health-information/patient-caregiver-education/hope-through-research/dementias-hope-through-research#treatment updated July 25 2022. Available from: [PubMed] [Google Scholar]
- 56.American Geriatric Society . 2022. A pocket guide to the AGS 2015 beers criteria 2015. [Google Scholar]
- 57.American Psychiatry Association Mind games 2014. https://www.apa.org/monitor/2014/10/mind-games updated October 14 2014. Available from:
- 58.World Health Organization Risk reduction of cognitive decline and dementia: WHO guidelines 2019. https://www.who.int/publications/i/item/9789241550543 updated January 1 2019. Available from: [PubMed]
- 59.National Health Service Overview Delirium (sudden confusion) 2020. https://www.guysandstthomas.nhs.uk/health-information/delirium-sudden-confusion updated June 2020. Available from:
- 60.National Institute for Health and Care Excellence Eating disorders: recognition and treatment 2020. https://www.nice.org.uk/guidance/ng69/resources/eating-disorders-recognition-and-treatment-pdf-1837582159813 updated December 16 2020. Available from: [PubMed]
- 61.American Family Physician Initial evaluation, diagnosis, and treatment of anorexia nervosa and bulimia nervosa 2015. https://www.aafp.org/pubs/afp/issues/2015/0101/p46.html updated January 1. Available from: [PubMed]
- 62.UpToDate Bulimia nervosa in adults: pharmacotherapy 2021. https://www.uptodate.com/contents/bulimia-nervosa-in-adults-pharmacotherapy?topicRef=2094&source=see_link#H1600853 updated April 28 2021. Available from:
- 63.World Health Organization . 2020. International standards for the treatment of drug use disorders.https://www.who.int/publications/i/item/international-standards-for-the-treatment-of-drug-use-disorders updated March 31 202. Available from: [Google Scholar]
- 64.American Psychiatry Association What is a substance use disorder? 2020. https://psychiatry.org/patients-families/addiction-substance-use-disorders/what-is-a-substance-use-disorder updated December 2020. Available from:
- 65.National Institute on Drug Abuse . 3rd ed. 2018. Principles of drug addiction treatment: a research-based guide.https://nida.nih.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/evidence-based-approaches-to-drug-addiction-treatment/pharmacotherapies updated January 2018. Available from: [Google Scholar]
- 66.Practice guideline for the treatment of patients with panic disorder. Work group on panic disorder. American psychiatric association. Am J Psychiatry. 1998;155(5 Suppl):1–34. [PubMed] [Google Scholar]
- 67.Allwood C., O'Brien A., Glue P. Referrals from primary care to community mental health teams: what's missing? J Prim Health Care. 2019;11(4):334–341. [Google Scholar]
- 68.Wadoo O., Ouanes S., Ahmed M.A.S., Saeid I.S.A., AlAbdulla S.A., AlAbdulla M. Improving referrals from primary care to secondary mental health services through an educational intervention: experience from Qatar. BJPsych Int. 2021;18(3):70–74. doi: 10.1192/bji.2021.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Rathod S., Pinninti N., Irfan M., et al. Mental health service provision in low- and middle-income countries. Health Serv Insights. 2017;10 doi: 10.1177/1178632917694350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Breuer E., De Silva M.J., Shidaye R., et al. Planning and evaluating mental health services in low- and middle-income countries using theory of change. Br J Psychiatry. 2016;208 Suppl 56(Suppl 56):s55–s62. doi: 10.1192/bjp.bp.114.153841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.World Health Organization . World Health Organization; 2001. Atlas of mental health resources in the world 2001. [Google Scholar]
- 72.Woolf S.H., Grol R., Hutchinson A., Eccles M., Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318(7182):527–530. doi: 10.1136/bmj.318.7182.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Lilford P., Wickramaseckara Rajapakshe O.B., Singh S.P. A systematic review of care pathways for psychosis in low-and middle-income countries. Asian J Psychiatr. 2020;54 doi: 10.1016/j.ajp.2020.102237. [DOI] [PubMed] [Google Scholar]
- 74.Sharifi V., Kermani-Ranjbar T., Amini H., Alaghband-rad J., Salesian N., Seddigh A. Duration of untreated psychosis and pathways to care in patients with first-episode psychosis in Iran. Early Interv Psychiatry. 2009;3(2):131–136. doi: 10.1111/j.1751-7893.2009.00119.x. [DOI] [PubMed] [Google Scholar]
- 75.Cabra-Bautista G., Florez I.D., Calvache J.A. Clinical practice guidelines in low and middle income countries: experiences from Colombia. J Clin Epidemiol. 2021;138:232–233. doi: 10.1016/j.jclinepi.2021.05.024. [DOI] [PubMed] [Google Scholar]
- 76.Pereira V.C., Silva S.N., Carvalho V.K.S., Zanghelini F., Barreto J.O.M. Strategies for the implementation of clinical practice guidelines in public health: an overview of systematic reviews. Health Res Pol Syst. 2022;20(1):13. doi: 10.1186/s12961-022-00815-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Setkowski K., Boogert K., Hoogendoorn A.W., Gilissen R., van Balkom A. Guidelines improve patient outcomes in specialised mental health care: a systematic review and meta-analysis. Acta Psychiatr Scand. 2021;144(3):246–258. doi: 10.1111/acps.13332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Blane D., Williams C., Morrison J., Wilson A., Mercer S. Cognitive behavioural therapy: why primary care should have it all. Br J Gen Pract. 2013;63(607):103–104. doi: 10.3399/bjgp13X663235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Cognitive Behavioral Therapy L.A. A course in CBT techniques: a free online CBT workbook 2020. https://cogbtherapy.com/free-online-cbt-workbook Available from:
- 80.Malhi G.S., Bell E., Morris G., Hamilton A. The delay in response to antidepressant therapy: a window of opportunity? Aust N Z J Psychiatry. 2020;54:127–129. doi: 10.1177/0004867419900313. [DOI] [PubMed] [Google Scholar]
- 81.Aguinaldo L.D., Sullivant S., Lanzillo E.C., et al. Validation of the ask suicide-screening questions (ASQ) with youth in outpatient specialty and primary care clinics. Gen Hosp Psychiatr. 2021;68:52–58. doi: 10.1016/j.genhosppsych.2020.11.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Watson T., Tindall R., Patrick A., Moylan S. Mental health triage tools: a narrative review. Int J Mental Health Nurs. 2022;inm doi: 10.1111/inm.13073. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

